NCT07380698 The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer
| NCT ID | NCT07380698 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cukurova University |
| Condition | Endometrial Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-10-03 |
| Primary Completion | 2026-08-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-10-03 with a primary completion date of 2026-08-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research will determine the impact of optimizing dosage and storage conditions for indocyanine green on health outcomes and will contribute to improving treatment processes in gynecological cancers. Ultrastaging will increase the detection of micrometastases. Furthermore, the cost impact of these optimizations will be evaluated. It will help develop more effective, safe, and cost-effective methods for sentinel lymph node mapping in gynecological cancers. Furthermore, significant savings in healthcare costs could be achieved.
Eligibility Criteria
Inclusion Criteria: * cervical cancer, endometrial cancer, vulvar cancer, using indocyanine green, sentinel lymph node dissection Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07380698 clinical trial?
This trial is open to female participants only, studying Endometrial Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07380698 currently recruiting?
Yes, NCT07380698 is actively recruiting participants. Contact the research team at ghanim.khatib@gmail.com for enrollment information.
Where is the NCT07380698 trial being conducted?
This trial is being conducted at Adana, Turkey (Türkiye).
Who is sponsoring the NCT07380698 clinical trial?
NCT07380698 is sponsored by Cukurova University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.